| Rachael Joan Winston, MD | |
|
1000 E Primrose St, Springfield, MO 65807-5154 | |
| (417) 269-9812 | |
| (417) 269-9853 |
| Full Name | Rachael Joan Winston |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 1000 E Primrose St, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205010022 | NPI | - | NPPES |
| 1205010022 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2010018546 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 1254248917 | 262 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447324660 PECOS PAC ID: 5799787784 Enrollment ID: O20070206000541 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Aids Project Of The Ozarks |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366634859 PECOS PAC ID: 4981771730 Enrollment ID: O20080922000178 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346602646 PECOS PAC ID: 5092624320 Enrollment ID: O20160517000289 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669923884 PECOS PAC ID: 1254248917 Enrollment ID: O20161206000652 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Cox-monett Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205387289 PECOS PAC ID: 0345236667 Enrollment ID: O20161213002029 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255870853 PECOS PAC ID: 5092624320 Enrollment ID: O20170310001975 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachael Joan Winston, MD Po Box 802843, Kansas City, MO 64180-2208 Ph: (417) 269-5712 | Rachael Joan Winston, MD 1000 E Primrose St, Springfield, MO 65807-5154 Ph: (417) 269-9812 |
News Archive
The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).
As human beings, we all know that we are going to die some day. Most of us deal with this knowledge by trying to live meaningful lives, but people with low self-esteem tend not to see their lives as particularly meaningful. Now, research suggests that touch may help people with low self-esteem in confronting their own mortality.
Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.
› Verified 4 days ago
Shalvinder Kaur Seehra, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3525 E Battlefield St, Springfield, MO 65809 Phone: 417-269-1499 Fax: 417-269-1459 | |
Harwinder K Dhanoa, Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Evergreen St, Springfield, MO 65803 Phone: 417-823-2900 | |
Thomas E Dahlberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3322 S Campbell Ave Ste T-1, Springfield, MO 65807 Phone: 417-220-4480 Fax: 417-414-0017 | |
Dr. John H Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 280, Springfield, MO 65807 Phone: 417-885-0834 Fax: 417-888-6763 | |
Dr. Jay L Sparks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 220, Springfield, MO 65807 Phone: 417-820-7450 Fax: 417-820-7455 | |
Dr. Conrad Mitchell Bajor, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2600 | |
Dr. William Russell Detten, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1530 E Republic Rd, Springfield, MO 65804 Phone: 417-269-1362 Fax: 417-269-1372 |